cAMP antagonizes interleukin 2-promoted T-cell cycle progression at a discrete point in early G1.
about
Cyclic AMP Represents a Crucial Component of Treg Cell-Mediated Immune RegulationInhibitory activity of fenoterol on Dermatophagoides-, Parietaria-, tetanus-toxoid-, and Candida albicans-stimulated blood mononuclear cells: differences in beta2-adrenoreceptor stimulation but not in cell apoptosis.Human monocytes respond to extracellular cAMP through A2A and A2B adenosine receptorsAdenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cellsInvolvement of cyclic adenosine monophosphate in the interleukin 4 inhibitory effect on interleukin 2-induced lymphokine-activated killer generation.Cyclic adenosine monophosphate is a key component of regulatory T cell-mediated suppression.Human immunodeficiency virus-infected adherent cell-derived inhibitory factor (p29) inhibits normal T cell proliferation through decreased expression of high affinity interleukin-2 receptors and production of interleukin-2Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2CD3+CD16+NK1.1+B220+ large granular lymphocytes arise from both alpha-beta TCR+CD4-CD8- and gamma-delta TCR+CD4-CD8- cells.Regulation of cytotoxic T lymphocyte antigen 4 by cyclic AMP.Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP.Altered peptide ligands act as partial agonists by inhibiting phospholipase C activity induced by myasthenogenic T cell epitopesModulation of T-cell activation through protein kinase C- or A-dependent signalling pathways synergistically increases human immunodeficiency virus long terminal repeat induction by cytomegalovirus immediate-early proteinsProtein kinase A-dependent binding of a nuclear factor to the 21-base-pair repeat of the human T-cell leukemia virus type I long terminal repeatEvidence for the implication of phosphoinositol signal transduction in mu-opioid inhibition of DNA synthesisCholera toxin and Escherichia coli heat-labile enterotoxin, but not their nontoxic counterparts, improve the antigen-presenting cell function of human B lymphocytesModulation of Phenotype and Function of Human CD4+CD25+ T Regulatory Lymphocytes Mediated by cAMP-Elevating AgentsDual signal transduction through delta opioid receptors in a transfected human T-cell line.Promoter activity of the proliferating-cell nuclear antigen gene is associated with inducible CRE-binding proteins in interleukin 2-stimulated T lymphocytes.CD2 signalling induces phosphorylation of CREB in primary lymphocytes.Block of T lymphocyte differentiation by activation of the cAMP-dependent signal transduction pathwayPhosphodiesterase isozymes: molecular targets for novel antiasthma agents.Cyclic AMP counteracts mitogen-induced inositol phosphate generation and increases in intracellular Ca2+ concentrations in human lymphocytes.Interleukin-2 induces gamma-S-adenosyl-L-methionine synthetase gene expression during T-lymphocyte activationCholera toxin treatment of vascular smooth muscle cells decreases smooth muscle alpha-actin content and abolishes the platelet-derived growth factor-BB-stimulated DNA synthesis.Activation of p70 S6 kinase and erk-encoded mitogen-activated protein kinases is resistant to high cyclic nucleotide levels in Swiss 3T3 fibroblasts.Time-course changes in content and fatty acid composition of phosphatidic acid from rat thymocytes during concanavalin A stimulation.Endothelial cell and cAMP regulation of T-cell CD40 ligand: relevance of calcium/calmodulin-dependent kinase IV signalling.
P2860
Q28072162-737C101D-FA1D-4BA7-A914-F97DF11725E9Q30873819-880BACDD-491F-41A5-9432-00B8C0B12CBFQ33750869-D03023B3-DF0E-4B37-876D-0AE44C079A25Q34107172-AC3DBD81-BCCC-4C8D-AF86-D93E5B4A2D34Q34253470-344115D4-D497-4895-BA10-831FD9827E31Q34579516-39444213-CA80-4ACF-96DA-00DE464F0310Q35603192-68052F57-D4FE-45EA-8606-A270EC165384Q35874125-D0A1347F-6AAF-4249-BB63-7FF709260DDCQ36363228-D49FB3AF-607D-40AD-9949-DC0079AD32FEQ36539552-223882B0-CFAD-4F60-9972-789502444FDFQ36566823-5F2409CA-CACA-41F9-8E55-47092A1D561FQ36733897-FB8340D5-3C44-44DA-A067-2A0C685BB6C1Q36798296-559AE336-52BA-4F23-9B26-CC79E0A45947Q36802382-F8601B83-F3F8-44DC-8184-195387A2B768Q36946616-A4CF6BA7-2B1E-46EE-B850-570874268329Q37191283-464BF0D7-B3DC-4CB0-9BA4-E7BA4534AFE3Q37266957-3A8B7D5F-33F5-4B58-B71A-058C00EBFB28Q37399792-2D6B9C64-BCB7-4D32-A205-3B045B75F9A1Q38307815-119F74FC-1804-4CD3-9AAF-1E67B558193FQ38329244-ADC4D9C7-F34F-46A2-AE59-3C3E093885BDQ41063816-EDEAD967-D561-41A4-94EE-A88C18422209Q41708863-130CA63A-F57C-434D-B520-3FDC14A2F5E6Q41850363-C1791267-674D-493D-9484-6E291BB07841Q42149102-417640DB-A992-4929-AC60-6EDAA5B10CE5Q42185471-2B7D91B6-FA4A-4F54-9C25-E037233CA01EQ42820812-F0A57D70-DCEA-47DE-8E7C-6D5DB98640D3Q42826460-4EEE0BDD-27B7-434A-94A0-73683CF940EFQ43977294-D19EAA46-2BAF-49AF-B666-71B981CA0BAE
P2860
cAMP antagonizes interleukin 2-promoted T-cell cycle progression at a discrete point in early G1.
description
1988 nî lūn-bûn
@nan
1988 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
cAMP antagonizes interleukin 2 ...... a discrete point in early G1.
@ast
cAMP antagonizes interleukin 2 ...... a discrete point in early G1.
@en
type
label
cAMP antagonizes interleukin 2 ...... a discrete point in early G1.
@ast
cAMP antagonizes interleukin 2 ...... a discrete point in early G1.
@en
prefLabel
cAMP antagonizes interleukin 2 ...... a discrete point in early G1.
@ast
cAMP antagonizes interleukin 2 ...... a discrete point in early G1.
@en
P2093
P2860
P356
P1476
cAMP antagonizes interleukin 2 ...... a discrete point in early G1.
@en
P2093
P2860
P304
P356
10.1073/PNAS.85.16.6072
P407
P577
1988-08-01T00:00:00Z